Medical/Pharmaceuticals
Breathonix announces 60 secs, on-site, non-intrusive rapid breath test for COVID-19
SINGAPORE, Oct. 29, 2020 /PRNewswire/ -- Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients. BREATHONIX BREATHLYZER TECHNOLOGY The principle of the breath test is fun...
2020-10-29 17:22
1937
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center inSan Francisco, bringing its contract development services closer to global clients. As the "Next Door ...
2020-10-29 08:38
6638
Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards
SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- On October 28, 2020, Yuyu Pharm (CEO Robert Wonsang Yu, KRX 000220) initiated steps to incorporate ISO 37001 Anti-bribery management system to strengthen the company's compliance system. During the introduction ceremony of ISO 37001 held at Yuyu P...
2020-10-28 21:00
1818
I-Mab Announces Upcoming Participation at November Conferences
SHANGHAI, China, and GAITHERSBURG, MD., Oct. 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences i...
2020-10-28 20:00
2746
Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019
SHIJIAZHUANG, China, Oct. 28, 2020 /PRNewswire/ -- On October 27, Yiling Pharmaceutical (002603.SZ) released its 2020 third quarter report. In the first three quarters of the year, Yiling Pharmaceutical achieved the total operating revenue of6.447 billion yuan (about US$962 million), a 48.31% yea...
2020-10-28 17:04
6629
Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic'
SEOUL, South Korea, Oct. 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...
2020-10-27 21:00
1298
VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center
SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...
2020-10-27 21:00
2075
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Oct. 27, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company will present the latest preclinical dat...
2020-10-27 20:05
4670
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study inthe United States. BioMUSE is a natur...
2020-10-27 10:03
3672
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ -- Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the ph...
2020-10-26 18:00
1498
"World's Firsts" Catching Eyes at Asia's Largest Medical Equipment Exhibition
SHANGHAI, Oct. 24, 2020 /PRNewswire/ -- With the global pandemic at the forefront, the 83rd China International Medical Equipment Fair (CMEF 2020) marked the world's largest offline exhibition for the medical sector, attracting many leading players to showcase their latest developments in medica...
2020-10-24 21:22
2521
Lianluo Smart Limited Announces 1-for-8 Reverse Stock Split
BEIJING, Oct. 23, 2020 /PRNewswire/ -- Lianluo Smart Limited ("LLIT" or the "Company") (NASDAQ: LLIT), aChina based professional smart service and products provider, today announced that the Company has effected a one-for-eight (1-for-8) reverse stock split of Class A common shares, par value$0.0...
2020-10-23 20:30
13865
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement
SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or "LOAC"), a publicly-traded special purpose acquisition company (SPAC), announced that it has signed a definitive merger agreement with 4D pharma PLC (AIM: DDDD, "4D pharma" or "4D"). Upon co...
2020-10-22 14:00
9304
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
INCHEON, South Korea, Oct. 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clini...
2020-10-20 19:00
9395
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing
INCHEON, South Korea, Oct. 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-generation immunotherapy to treat cancer. Under this agreement, Samsung Biologics will provide a full scope of its ...
2020-10-19 19:00
10303
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical") signed a strategic partnership agreement in Shanghai. Mrs. LIU Jingping, Chairperson of Huluwa Pharmace...
2020-10-16 05:40
16501
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") and Guangzhou Xiangxue Pharmaceutical Co., Ltd. ("Xiangxue Pharmaceutical") officially signed a strategic partnership agreement (the "Agreement") to deepen collaboration to further develop the "Internet + ...
2020-10-16 05:35
15018
MedTech Startup See-Mode Technologies Receives FDA Clearance for AI Software That Automatically Analyses and Reports Vascular Ultrasound Scans
SINGAPORE, Oct. 15, 2020 /PRNewswire/ -- See-Mode Technologies
2020-10-15 21:00
2725
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
SEOUL, South Korea, Oct. 14, 2020 /PRNewswire/ -- A recent pilot project conducted by a South Korean medical AI company, Lunit, and one of the largest Taiwanese insurance companies, Cathay Life Insurance, reveals that AI can help the current underwriting process to be more accurate and efficient....
2020-10-14 22:00
2505
More than one third of Australian employees are less motivated at work than before the pandemic
Morneau Shepell's Mental Health Index™ rises slightly in September MELBOURNE, Oct. 14, 2020 /PRNewswire/ -- Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today released its monthly Mental Health Index™ report, making September the sixth ...
2020-10-14 05:00
1957
Week's Top Stories
Most Reposted
ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER
[Picked up by 308 media titles]
2025-01-07 09:00
RuggON Unveils VORTEX Vehicle Mount Computer with AI-Enhanced, SATCOM-Ready
[Picked up by 306 media titles]
2025-01-06 21:00
Brewing Connections and Spotlighting Café Culture: MIFB 2025 Hosts MNCC in Collaboration with MSCA
[Picked up by 305 media titles]
2025-01-06 14:00
iWOW Unveils Age-Tech Innovations at CES 2025, Expanding Portfolio of IoT Solutions for Ageing-In-Place
[Picked up by 293 media titles]
2025-01-07 21:18CELEBRATE THE LUNAR NEW YEAR 2025 AT HOIANA RESORT & GOLF, WORLD'S LEADING FULLY INTEGRATED RESORT
[Picked up by 290 media titles]
2025-01-06 19:25
Most Read
Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave
2025-01-03 19:33
10644
Russell Reynolds Associates Appoints Euan Kenworthy as Singapore Country Manager
2025-01-02 08:16
8340
PieX AI: Launching the World's First Personalized, On-device AI Pendant at CES 2025
2025-01-02 21:00
6622
